113 results
Page 3 of 6
8-K
EX-99.1
zt05ukhnrz2n 12up2
29 Apr 21
Agios Reports Business Highlights and First Quarter 2021 Financial Results
7:28am
8-K
EX-99.1
ch4 sxjajm2
25 Feb 21
Agios Reports Fourth Quarter and Full Year 2020 Financial Results
7:17am
DEFM14A
50m cusz4u6etr
11 Feb 21
Proxy related to merger
4:19pm
PREM14A
5zn mr1z18
29 Jan 21
Preliminary proxy related to merger
4:22pm
8-K
EX-99.1
0h36z
26 Jan 21
Other Events
4:14pm
DEFA14A
iojaqo2qpkxpim7b
12 Jan 21
Additional proxy soliciting materials
5:15pm
DEFA14A
6zo24fqospdpn2okxaf
11 Jan 21
Additional proxy soliciting materials
7:17am
8-K
EX-99.1
nak0ywft w63taob1
11 Jan 21
Agios Highlights 2021 Milestones to Accelerate and Expand Its Genetically Defined Disease Portfolio and Drive Near- and Long-Term Value Creation
7:14am
DEFA14A
EX-99.2
smy kkpgf9
21 Dec 20
Additional proxy soliciting materials
7:10am
8-K
EX-99.2
r2x4z4kt3czkuplp
21 Dec 20
Regulation FD Disclosure
7:04am
8-K
EX-99.1
52lvo5vszi5lheqe
7 Dec 20
Agios Announces Updated Data from Phase 1 Study of Mitapivat, First-in-Class PKR Activator, in Sickle Cell Disease
4:53pm
8-K
EX-99.1
e2nozlu 9ta6rrr0c
1 Dec 20
Other Events
7:46am
8-K
EX-99.1
4dln54hwkrag
5 Nov 20
Agios Reports Business Highlights and Third Quarter 2020 Financial Results
7:32am
8-K
EX-99.1
5b2lwbcumyqtoeg90o0h
21 Sep 20
Other Events
7:14am
8-K
EX-99.1
33ghj0o 0471r61w2qt6
8 Sep 20
Agios Appoints Jonathan Biller as Chief Financial Officer, Head of Legal and Corporate Affairs
4:09pm
8-K
EX-99.1
30wm0v
30 Jul 20
Agios Reports Business Highlights and Second Quarter 2020 Financial Results
7:17am
8-K
EX-99.3
zrfodn
12 Jun 20
Entry into a Material Definitive Agreement
7:04am